D-0248-2025 Class II Terminated

Recalled by Turbare Manufacturing — Conway, AR

FDA drug recall D-0248-2025 was initiated by Turbare Manufacturing on Feb 18, 2025 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: due to a quality control process deviation The recall status is terminated (terminated Feb 26, 2026). Affected quantity: 1,147 syringes.

Recall details

Product Type
Drugs
Report Date
Mar 5, 2025
Initiation Date
Feb 18, 2025
Termination Date
Feb 26, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,147 syringes

Product description

Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.

Reason for recall

Lack of Assurance of Sterility: due to a quality control process deviation

Distribution pattern

Nationwide in the USA

Code information

Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025).

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0248-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0248-2025. Report a data issue: hello@regdatalab.com.